Early Study Shows Pfizer Vaccine Effective

  • 08-Jan-2021
  • Comments

The COVID-19 vaccine from pharmaceutical companies Pfizer and BioNTech looks to be effective against 16 different mutations of the coronavirus. 

A strict study by researchers at Pfizer and the University of Texas Medical Branch, suggests the vaccine will not need to be tweaked in order to work against a seemingly more contagious variant of the coronavirus that arose in the UK.


The British variant, known as B117, was recently detected in the United States among people who had not traveled to the UK, indicating community spread. Viral mutations are a typical occurrence and there is no indication that any to date have made COVID-19 more dangerous than it already is.